12-74538293-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001136262.2(ATXN7L3B):c.181A>T(p.Ile61Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,408,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001136262.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000606 AC: 1AN: 165150Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 87404
GnomAD4 exome AF: 0.00000142 AC: 2AN: 1408790Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 695678
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.181A>T (p.I61F) alteration is located in exon 1 (coding exon 1) of the ATXN7L3B gene. This alteration results from a A to T substitution at nucleotide position 181, causing the isoleucine (I) at amino acid position 61 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at